Batch receives KL2 Scholar Award

Research Conference 1/31/14: Rx: Mild Stress: A new prescription for living healthier and longer

David D'Alessio chosen to be chief of Division of Endocrinology
Mary Klotman, MD, chair of the Department of Medicine, announced today that David D’Alessio, MD, has agreed to be the Chief of the Division of Endocrinology, Metabolism and Nutrition, effective November 26, 2013. (He will begin full time in April 2014.)
Currently, Dr. D'Alessio is Professor of Medicine and the Albert Vontz Chair for Diabetes Research at the University of Cincinnati, where he also serves as Director of the Division of Endocrinology.
McNeill to receive Patient Care Award from ADA

McNeill to lead new SoM academy focused on health professions education

Grand Rounds 8/9/13: Diabetes drug safety
Medicine Grand Rounds on Fri., Aug. 9 at 8 a.m. in Duke Hospital room 2002 will feature Jennifer Green, MD, associate professor of medicine (Endocrinology, Metabolism and Nutrition) and chief of the Endocrine Section at the Durham VA Medical Center, and a case presentation by Jennifer Rymer, MD, MBA, senior assistant resident.
Dr.
Grand Rounds 2/15/13: Obesity and diabetes
Medicine Grand Rounds on Fri., Feb. 15 at 8 a.m. in Duke Hospital room 2002 will feature Lillian Lien, MD, medical director of Duke Inpatient Diabetes Management and assistant professor of medicine (Endocrinology, Metabolism and Nutrition) and Christopher Newgard, PhD, director of the Sarah W. Stedman Nutrition and Metabolism Center and W. David and Sarah W.
Slow-release 'jelly' is novel drug deliverer
Mark N. Feinglos, MD, CM, professor of medicine (Endocrinology, Metabolism and Nutrition) and associate professor of Pathology and Psychiatry and Behavioral Sciences, is part of a team of Duke researchers who have developed a new method to overcome major hurdles facing a promising new class of peptide drugs to treat diseases such as diabetes and cancer.